Global Coronary Stents Market, By Product Type (Bare-metal Stents, Drug Eluting Stents, and Bioabsorbable Stents), By Material (Metallic (Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, and Others) and Polymeric (Non-degradable/Permanent Stents and Degradable/Temporary Stents)), By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 8,985.6 million in 2020 and is expected to exhibit a CAGR of 7.7% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Key players operating in the market are focusing on development of technologically advanced coronary stents which is expected to drive the market growth during the forecast period.

For instance, in 2017, CeloNova BioSciences Inc. evaluated its proprietary Cobra PzF Nanocoated Coronary Stents (NCS) in patients with high bleeding risk. Nanocoated coronary stents are an alternate therapy for patients incompatible with drug eluting stents and long term antiplatelet therapy.

Moreover, Abbott received the U.S. FDA approval for its technologically advanced coronary stent Xience Sierra in May 2018, which is a XIENCE everolimus-eluting coronary stent system. The stent was specifically intended for treating complex arterial blockage.

Global Coronary Stents Market – Impact of Coronavirus (Covid-19) Pandemic

The COVID-19 pandemic has majorly impacted the global economy and in turn, the coronary stents market. Quarantine, traveling constraints, and social distancing measures are likely to lead to a steep decline in business and consumer spending until the end of the second quarter of 2020. Moreover, governments are taking initiatives to combat the COVID-19 pandemic. For instance, in May 2020, the Centers for Disease Control and Prevention (CDC) worked with the All-of-Government and All-of-America approach to increase testing capacity and availability to improve case detection and contact tracing across all states in the U.S.

Moreover, the CDC is working with the state and local partners to define the circumstances where testing of asymptomatic persons is likely to be helpful in controlling the pandemic, as well as the best application of surveillance serologic testing.

Browse 41 Market Data Tables and 30 Figures spread through 198 Pages and in-depth TOC on “Coronary Stents Market”- Global Forecast to 2027, By Product Type (Bare-metal Stents, Drug Eluting Stents, and Bioabsorbable Stents), By Material (Metallic (Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, and Others) and Polymeric (Non-degradable/Permanent Stents and Degradable/Temporary Stents)), By End User (Hospitals, Specialty Clinics and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),

To know the latest trends and insights prevalent in the global coronary stents market, click the link below:

https://www.coherentmarketinsights.com/market-insight/coronary-stents-market-2031

The coronary stents market growth is driven by reimbursement coverage provided to the people by the Medicare and Medicaid Services (CMS) and private payers. The coverage is availed under the national coverage determination in U.S. for carotid artery stenting including products and service providers. From January 2020, the Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in ambulatory surgical centers which is expected to drive the market growth during the forecast period.

Key Takeaways of the Global Coronary Stents Market:

  • The global coronary stents market is expected to expand at a CAGR of 7.7% during the forecast period owing to the increasing competition among market players to launch new products in the market and increasing research and development for development of novel product. For instance, in September 2018, MicroPort Scientific Corporation, a China-based healthcare company developed ‘Firehawk’, a drug-eluting stent that is used for treating patients with coronary artery disease. Firehawk is a new generation Rapamycin target eluting coronary stent system.
  • Among product type, the bare-metal stents segment accounted for the largest market share in 2019 owing to a wide product range and excellent mechanical properties and corrosion resistance.
  • Key players operating in the global coronary stents market are Boston Scientific Corporation, Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner